rhodamine 123 has been researched along with pyruvaldehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allgaier, C; Camins, A; de Arriba, SG; García-Jordá, E; Krügel, U; Lewerenz, A; Münch, G; Nieber, K; Pallas, M; Regenthal, R; Verdaguer, E; Vissiennon, Z | 1 |
| Dai, H; He, P; Hu, Y; Li, W; Ni, Z; Xu, H; Zhang, Z | 1 |
2 other study(ies) available for rhodamine 123 and pyruvaldehyde
| Article | Year |
|---|---|
Carbonyl stress and NMDA receptor activation contribute to methylglyoxal neurotoxicity.
Topics: Adenosine Triphosphate; Biological Transport; Cell Line, Tumor; Cell Membrane; Glutamic Acid; Humans; Membrane Potentials; Mitochondria; Neurons; Pyruvaldehyde; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Rhodamine 123 | 2006 |
Edaravone protected human brain microvascular endothelial cells from methylglyoxal-induced injury by inhibiting AGEs/RAGE/oxidative stress.
Topics: Antipyrine; Blotting, Western; Brain; Diabetes Complications; Edaravone; Endothelial Cells; Glycation End Products, Advanced; Humans; Microvessels; Oxidative Stress; Pyruvaldehyde; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Rhodamine 123; Tetrazolium Salts; Thiazoles | 2013 |